The effect of decreased plasma cholesterol concentration on circulatinga mevalonate metabolism in rats.
Circulating mevalonate is metabolized by two mechanisms: the sterol pathways leading to cholesterol and the shunt pathway resulting in CO2 production. The kidney is the chief site of circulating mevalonate metabolism by both pathways. The present study investigated the effect of plasma cholesterol c...
Main Authors: | K R Feingold, M H Wiley, G MacRae, M D Siperstein |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
1981-08-01
|
Series: | Journal of Lipid Research |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0022227520373363 |
Similar Items
-
Mevalonate metabolism by renal tissue in vitro
by: Philip Raskin, et al.
Published: (1974-01-01) -
Cholesterol and mevalonate metabolism: a time course study in vivo*
by: J.C. Elwood, et al.
Published: (1961-10-01) -
Urinary clearance and metabolism of mevalonate by the isolataed perfused rat kidney.
by: H Brunengraber, et al.
Published: (1981-08-01) -
HSF1 Regulates Mevalonate and Cholesterol Biosynthesis Pathways
by: Hyeji Kang, et al.
Published: (2019-09-01) -
The “Mevalonate hypothesis”: a cholesterol-independent alternative for the etiology of atherosclerosis
by: Keizer Hiskias G
Published: (2012-11-01)